Medicine & Life Sciences
Nanoparticles
100%
Nanomedicine
55%
Lipids
49%
RNA Interference
40%
Leukocytes
36%
Neoplasms
27%
Small Interfering RNA
26%
Hyaluronic Acid
24%
RNA
24%
Gene Silencing
23%
Therapeutics
21%
Integrins
19%
Pharmaceutical Preparations
19%
Multiple Drug Resistance
18%
Messenger RNA
17%
Nucleic Acids
13%
Fluoxetine
12%
Lymphocytes
11%
RNAi Therapeutics
11%
Gene Editing
11%
Lymphocyte Function-Associated Antigen-1
10%
Antibodies
10%
Clustered Regularly Interspaced Short Palindromic Repeats
10%
Mantle-Cell Lymphoma
10%
Theranostic Nanomedicine
9%
Cyclin D1
8%
Liposomes
8%
Heterografts
7%
Mitomycin
7%
Immune System
7%
Nanotechnology
7%
Inflammatory Bowel Diseases
7%
Doxorubicin
7%
Technology
6%
Sertraline
6%
In Vitro Techniques
6%
Immunomodulation
6%
Gene Expression
6%
Vaccines
6%
Precision Medicine
6%
Exosomes
6%
Colitis
6%
Drug Therapy
6%
Proteins
5%
Anti-Inflammatory Agents
5%
Genes
5%
Head and Neck Neoplasms
5%
Cytokines
5%
ATP Binding Cassette Transporter, Subfamily B, Member 1
5%
Polysaccharides
5%
Engineering & Materials Science
Lipids
71%
Nanoparticles
70%
Medical nanotechnology
68%
RNA
36%
Messenger RNA
27%
Tumors
27%
Nanotechnology
17%
Theranostics
16%
Nucleic acids
16%
Cells
15%
Toxicity
14%
Molecules
13%
Vaccines
13%
Personalized medicine
12%
Genes
12%
Tissue
11%
Oncology
10%
Chemotherapy
9%
Antibodies
8%
Proteins
8%
Transparency
8%
Drug delivery
7%
Micelles
7%
Nanostructured materials
7%
Interferons
7%
Cell death
7%
Cytokines
6%
Immune system
6%
Molecular imaging
6%
Animals
5%
Imaging techniques
5%
Peptides
5%
Chemical activation
5%
Nanoclusters
5%
Oxygenases
5%
Medicine
5%
Heterografts
5%
Tissue engineering
5%
Enzymes
5%
Chemistry
Nanoparticle
61%
Lipid
50%
Drug
27%
Nanocarrier
20%
Silencing RNA
19%
Small Interfering RNA
19%
Application
14%
Nucleic Acid
11%
Molecule
10%
Protein
9%
Liposome
8%
Transparency
8%
Glycosaminoglycan
7%
Haematological
7%
Doxorubicin
7%
Messenger RNA
6%
Polysaccharide
6%
Combinatorial Library
6%
Resistance
5%
Mitomycin C
5%
Heterogeneity
5%
Disorder
5%
